St. Mary’s Medical Center in Huntington would operate as a stand-alone facility after its takeover by Cabell Huntington Hospital under an antitrust agreement announced Friday by West Virginia Attorney General Patrick Morrisey.
Morrisey said the agreement filed Friday in Cabell County Circuit Court sets conditions to ensure the acquisition complies with state and federal law. The acquisition is still under review by the Federal Trade Commission.
In November, Cabell Huntington Hospital Inc. agreed to assume control of St. Mary’s after the Pallottine Missionary Sisters ended their sponsorship of the hospital after 90 years.
St. Mary’s has 393 beds and Cabell Huntington has 303 beds. They are the top two private employers in Cabell County. The combined operation would represent the second-largest hospital chain in the state behind Charleston Area Medical Center.
“Unfortunately, with the recent increased federal regulation in the health care industry, the trend of hospital consolidation will likely increase over the coming years as hospitals struggle to deal with the increased costs of regulation,” Morrisey said. “However, I believe given the conditions negotiated in our agreement, the best interests of our citizens will be protected.”
Full content: The Herald-Dispatch
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas